Clinical Trials Directory

Trials / Completed

CompletedNCT06275425

Comparison of the Coughing Frequency of Remimazolam Total Intravenous Anesthesia Versus Inhalational Anesthesia

Comparison of the Coughing Frequency of Remimazolam Total Intravenous Anesthesia Versus Inhalational Anesthesia : a Single-blinded Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
106 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

This study is a randomized controlled trial. Adult patients undergoing thyroidectomy under general anesthesia at Severance Hospital and Yonsei Cancer Center are included in tis study. For intervention group, patients receive anesthesia with total intravenous remimazolam, while for control group, patients receive anesthesia with inhalation anesthetic. The primary end point of the study is to determine whether coughing during endotracheal tube extubation is less when anesthesia is maintained with intravenous remimazolam compared to inhalation anesthetics. The secondary end points are cough score (graded into 4 levels), frequency of reoperation due to postoperative bleeding, These include the frequency of hypertension during the extubation process and whether additional painkillers are used in the recovery room.

Conditions

Interventions

TypeNameDescription
DRUGTotal intravenous anesthesia with ByfavoGeneral anesthesia is maintained with intravenous continuous administration of Byfavo.
DRUGInhalation anesthesia with SevofluraneGeneral anesthesia is maintained with Sevoflurane.

Timeline

Start date
2023-06-25
Primary completion
2023-11-29
Completion
2023-11-29
First posted
2024-02-23
Last updated
2024-02-23

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06275425. Inclusion in this directory is not an endorsement.